NLS Pharmaceutics Ownership | Who Owns NLS Pharmaceutics?


OverviewChart

NLS Pharmaceutics Ownership Summary


NLS Pharmaceutics is owned by 32.46% insiders, and 67.54% retail investors. SFR Global Wealth Fund is the top mutual fund, with 0.05% of its assets in NLS Pharmaceutics shares.

NLSP Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockNLS Pharmaceutics-32.46%67.54%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20251-36---1---
Jun 30, 2024928.57%8,526,8524.52%224.89%525.00%1-
Mar 31, 2024740.00%8,157,93239.91%219.16%4---100.00%
Dec 31, 20235-28.57%5,830,804-7.36%150.55%--100.00%1-50.00%
Sep 30, 20237-22.22%6,294,283-2.58%521.79%2-60.00%2100.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
SFR Global Wealth Fund2.50K0.05%-
Fidelity Nasdaq Composite Index358.000.01%-

NLSP Ownership FAQ


Who Owns NLS Pharmaceutics?

NLS Pharmaceutics shareholders are primarily institutional investors at 0.00%, followed by 32.46% insiders and 67.54% retail investors. The average institutional ownership in NLS Pharmaceutics's industry, Biotech Stocks , is 306.59%, which NLS Pharmaceutics falls below.

Does Blackrock own NLS Pharmaceutics?

BlackRock is not among the top 10 institutional shareholders of NLS Pharmaceutics.

Who is the top mutual fund holder of NLS Pharmaceutics shares?

SFR Global Wealth Fund is the top mutual fund holder of NLS Pharmaceutics shares, with 0.05% of its total shares outstanding invested in 2.5K NLS Pharmaceutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools